stella
beta
Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma — Stella
Recruiting
Back to Unresectable Locally Advanced or Metastatic Melanoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
BeiJing Cancer Hospital EC, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov